Advertisement

Tumor Biology

, Volume 35, Issue 2, pp 1323–1330 | Cite as

Polymorphisms in the vitamin D receptor gene and the lung cancer risk

Research Article

Abstract

The relationship between the vitamin D receptor (VDR) polymorphisms and the susceptibility to lung cancer remains unclear. The present meta-analysis was performed to estimate the polymorphisms of VDR and lung cancer risk. The pooled odds ratios (ORs) and corresponding 95 % confidence intervals (CIs) were calculated. Subgroup analysis by smoking status was carried out for further elucidation. The VDR BsmI polymorphism seemed to be negatively associated with the lung cancer risk (A vs. G, OR = 0.71, 95 % CI, 0.52–0.96; GA vs. GG, OR = 0.54, 95 % CI, 0.35–0.83; AA + GA vs. GG, OR = 0.55, 95 % CI, 0.36–0.84), particularly among the smokers (AA + GA vs. GG, OR = 0.39, 95 % CI, 0.21–0.72). The VDR ApaI variant genotypes did not alter the risk of lung cancer under all gene models in overall analysis. However, smokers carrying the variant G allele were more susceptible to lung cancer (G vs. T, OR = 1.60, 95 % CI, 1.14–2.25). The polymorphism of VDR TaqI was related to a decreased risk of lung cancer (C vs. T, OR = 0.62, 95 % CI, 0.26–1.46; CC vs. TT, OR = 0.44, 95 % CI, 0.21–0.91; TC vs. TT, OR = 0.58, 95 % CI, 0.38–0.90; CC + TC vs. TT, OR = 0.55, 95 % CI, 0.36–0.84). Besides, the CC + TC carriers in the smokers were at a significantly reduced risk of lung cancer (CC + TC vs. TT, OR = 0.48, 95 % CI, 0.16–1.44). The study supports that the polymorphisms of VDR BsmI and TaqI play protective roles in the lung carcinogenesis, particularly among the smokers. The association of VDR ApaI polymorphism with the lung cancer risk needs to be further elucidated.

Keywords

Vitamin D receptor Lung cancer Polymorphism Meta-analysis 

Notes

Conflicts of interest

None.

References

  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  2. 2.
    Pan H, Niu W, He L, Wang B, Cao J, Zhao F, et al. Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese. PLoS One. 2013;8:e69018.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Wei W, He XF, Qin JB, Su J, Li SX, Liu Y, et al. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:11249–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Kiyohara C, Takayama K, Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer. 2006;54:267–83.PubMedCrossRefGoogle Scholar
  5. 5.
    Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20:605–18.PubMedCrossRefGoogle Scholar
  6. 6.
    Hackshaw AK. Lung cancer and passive smoking. Stat Methods Med Res. 1998;7:119–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Olivo-Marston SE, Yang P, Mechanic LE, Bowman ED, Pine SR, Loffredo CA, et al. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18:3375–83.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, et al. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int J Cancer. 2003;104:758–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Schneider J, Classen V, Bernges U, Philipp M. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med. 2005;16:709–16.PubMedGoogle Scholar
  10. 10.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997;154(Suppl):S57–73.PubMedGoogle Scholar
  11. 11.
    Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, et al. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res. 2010;70:1496–504.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Raje M, Botre C, Ashma R. Genetic epidemiology of osteoporosis across four microsatellite markers near the VDR gene. Int J Mol Epidemiol Genet. 2013;4:101–8.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29:3511–36.PubMedGoogle Scholar
  14. 14.
    Mohapatra S, Saxena A, Gandhi G, Koner BC, Ray PC. Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population. J Ovarian Res. 2013;6:37.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Gonzalez-Parra E, Rojas-Rivera J, Tunon J, Praga M, Ortiz A, Egido J. Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant. 2012;27 Suppl 4:iv17–21.PubMedCrossRefGoogle Scholar
  16. 16.
    Kaleta B, Bogaczewicz J, Robak E, Sysa-Jedrzejowska A, Wrzosek M, Szubierajska W, et al. Vitamin D receptor gene BsmI polymorphism in Polish patients with systemic lupus erythematosus. ISRN Endocrinol. 2013;2013:427818.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Torok R, Torok N, Szalardy L, Plangar I, Szolnoki Z, Somogyvari F, et al. Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians. Neurosci Lett. 2013Google Scholar
  19. 19.
    Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, et al. Polymorphisms in the vitamin D receptor gene and risk of lung cancer. Med Sci Monit. 2009;15:BR232–42.PubMedGoogle Scholar
  20. 20.
    Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.PubMedGoogle Scholar
  21. 21.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRefGoogle Scholar
  22. 22.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  23. 23.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  24. 24.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  25. 25.
    Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.PubMedCrossRefGoogle Scholar
  26. 26.
    Tang LJ, Yang YH, Cai LN, Yu ZY, Qi XM, Fu ZZ. Relationship of vitamin D receptor BsmI and TaqI polymorphisms with the non-small cell lung cancer susceptibility. Shandong Med J. 2012;52:40–1 [Article in Chinese].Google Scholar
  27. 27.
    Cai LN. Relationship of vitamin D receptor gene polymorphisms with advanced non-small cell lung cancer susceptibility and sensitivity to chemotherapy. Chengde Medical College. 2009. [Article in Chinese]Google Scholar
  28. 28.
    Thompson PD, Remus LS, Hsieh JC, Jurutka PW, Whitfield GK, Galligan MA, et al. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J Mol Endocrinol. 2001;27:211–27.PubMedCrossRefGoogle Scholar
  29. 29.
    Di Rosa M, Malaguarnera L, Nicolosi A, Sanfilippo C, Mazzarino C, Pavone P, et al. Vitamin D3: an ever green molecule. Front Biosci (Schol Ed). 2013;5:247–60.CrossRefGoogle Scholar
  30. 30.
    Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002;147:197–213.PubMedCrossRefGoogle Scholar
  31. 31.
    Gunduz M, Cacina C, Toptas B, Yaylim-Eraltan I, Tekand Y, Isbir T. Association of vitamin D receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers. 2012;16:1058–61.PubMedCrossRefGoogle Scholar
  32. 32.
    Mostowska A, Sajdak S, Pawlik P, Lianeri M, Jagodzinski PP. Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet Test Mol Biomarkers. 2013;17:183–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Mostowska A, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP. Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep. 2013;40:803–10.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Polic MV, Rucevic I, Barisic-Drusko V, Miskulin M, Glavas-Obrovac L, Stefanic M, et al. Polymorphisms of vitamin D receptor gene in the population of eastern Croatia with psoriasis vulgaris and diabetes mellitus. Coll Antropol. 2012;36:451–7.PubMedGoogle Scholar
  35. 35.
    Li L, Wu B, Yang L, Yin G, Wei W, Sui S, et al. Association of vitamin D receptor gene polymorphisms with pancreatic cancer: a pilot study in a North China Population. Oncol Lett. 2013;5:1731–5.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1003–16.PubMedCrossRefGoogle Scholar
  37. 37.
    Falleti E, Bitetto D, Fabris C, Cussigh A, Fontanini E, Fornasiere E, et al. Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol. 2010;16:3016–24.PubMedCrossRefGoogle Scholar
  38. 38.
    Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371:1–12.PubMedCrossRefGoogle Scholar
  39. 39.
    Dey SK, Jha S, Ghosh I, Bhattacharya SK, Das A, Gangopadhyay S. Knowledge, attitude and practice of smoking in subjects of lung cancer. J Indian Med Assoc. 2012;110:880–4.PubMedGoogle Scholar
  40. 40.
    Everatt R, Kuzmickiene I, Senulis A. Cigarette smoking and trends in lung cancer incidence in Lithuania: an analysis by histological type. Med (Kaunas). 2011;47:222–9.Google Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  1. 1.Department of Emergency Internal MedicineTangshan Worker’s HospitalTangshanChina
  2. 2.Department of Infectious DiseaseTangshan Worker’s HospitalTangshanChina

Personalised recommendations